Recommend Cell Cycle to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Report

The NFAT1 Transcription Factor is a Repressor of Cyclin A2 Gene Expression

Lilian D.S. Carvalho, Leonardo K. Teixeira, Nina Carrossini, Anita T.N. Caldeira, K. Mark Ansel, Anjana Rao and Joao Viola

volume 6 | issue 14

15 July 2007
Pages: 1789 - 1795

Purchase article for $19

Subscribe to this journal for $129/year

The NFAT (Nuclear Factor of Activated T cells) family of transcription factors plays a central role in the regulation of several genes related to the immune response. Recently, NFAT proteins have been implicated in the proliferation and differentiation of different cell types. Previous studies have shown that NFAT1-deficient mice display lymphocyte hyperproliferation, shortened cell cycle duration, and cyclin overexpression. Here, we demonstrate that cyclin A2 expression is upregulated in the absence of NFAT1 in lymphocytes. Ectopic expression of NFAT1 in CHO cells decreases cyclin A2 levels. Indeed, NFAT1 binds to a consensus binding site found at the mouse cyclin A2 promoter in vitro and in vivo. Luciferase reporter assays show that NFAT1 downregulates cyclin A2 expression by directly binding to the cyclin A2 promoter. Together, these results indicate that the NFAT1 transcription factor represses cyclin A2 expression in lymphocytes, and may act as a silencer of gene transcription during the cell cycle.

Authors

Lilian D.S. Carvalho

National Cancer Institute (INCA); Rio de Janeiro, Brazil

Leonardo K. Teixeira

National Cancer Institute (INCA); Rio de Janeiro, Brazil

Nina Carrossini

National Cancer Institute (INCA); Rio de Janeiro, Brazil

Anita T.N. Caldeira

National Cancer Institute (INCA); Rio de Janeiro, Brazil

K. Mark Ansel

Harvard Medical School; Boston, Massachusetts

Anjana Rao

Harvard Medical School; Boston, Massachusetts

Joao Viola

National Cancer Institute (INCA); Rio de Janeiro, Brazil


Purchase article for $19

Subscribe to this journal for $129/year